MX379693B - Formulaciones de moxidectina inyectables de larga acción y formas de cristal de moxidectina novedosas. - Google Patents

Formulaciones de moxidectina inyectables de larga acción y formas de cristal de moxidectina novedosas.

Info

Publication number
MX379693B
MX379693B MX2018009965A MX2018009965A MX379693B MX 379693 B MX379693 B MX 379693B MX 2018009965 A MX2018009965 A MX 2018009965A MX 2018009965 A MX2018009965 A MX 2018009965A MX 379693 B MX379693 B MX 379693B
Authority
MX
Mexico
Prior art keywords
moxidectin
long
formulations
novel
crystal forms
Prior art date
Application number
MX2018009965A
Other languages
English (en)
Inventor
Baoqing Ma
Chunhua Yang
Robert Clark Chapman
Susan Mancini Cady
Uday Jain
Original Assignee
Merial Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merial Ltd filed Critical Merial Ltd
Publication of MX379693B publication Critical patent/MX379693B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/22—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains four or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

La invención proporciona formas de moxidectina antiparasíticas y pesticidas novedosas, que incluye un implante polimérico de larga acción. Los compuestos resultantes se pueden utilizar en composiciones veterinarias que se usan en el tratamiento, control y prevención de infecciones por endo- y ectoparásitos en animales.
MX2018009965A 2011-12-02 2012-11-30 Formulaciones de moxidectina inyectables de larga acción y formas de cristal de moxidectina novedosas. MX379693B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161566336P 2011-12-02 2011-12-02
PCT/US2012/067215 WO2013082373A1 (en) 2011-12-02 2012-11-30 Long-acting injectable moxidectin formulations and novel moxidectin crystal forms

Publications (1)

Publication Number Publication Date
MX379693B true MX379693B (es) 2025-03-11

Family

ID=47324470

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2018009965A MX379693B (es) 2011-12-02 2012-11-30 Formulaciones de moxidectina inyectables de larga acción y formas de cristal de moxidectina novedosas.
MX2014006601A MX358476B (es) 2011-12-02 2012-11-30 Formulaciones de moxidectina inyectables de larga acción y formas de cristal de moxidectina novedosas.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2014006601A MX358476B (es) 2011-12-02 2012-11-30 Formulaciones de moxidectina inyectables de larga acción y formas de cristal de moxidectina novedosas.

Country Status (14)

Country Link
US (2) US8715711B2 (es)
EP (2) EP2785719B1 (es)
CN (2) CN105232529B (es)
AU (4) AU2012345813B2 (es)
BR (2) BR122020002199B1 (es)
CA (2) CA2857958C (es)
DK (2) DK2785719T3 (es)
ES (2) ES2659159T3 (es)
HU (2) HUE036441T2 (es)
MX (2) MX379693B (es)
PL (2) PL3351546T3 (es)
PT (2) PT2785719T (es)
WO (1) WO2013082373A1 (es)
ZA (1) ZA201404122B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014169092A1 (en) * 2013-04-12 2014-10-16 Zoetis Llc Composition of macrocyclic lactones, levamisole, an amino sugar and an additional antiparasitic agent
CN103405388B (zh) * 2013-08-21 2015-04-08 成都乾坤动物药业有限公司 一种可湿性莫西菌素固体分散粉及其制备方法和用途
FR3028314B1 (fr) * 2014-11-07 2016-12-23 Aircelle Sa Procede de caracterisation du vieillissement thermique de materiaux composites, en particulier de materiaux composites a matrice organique
WO2016164487A1 (en) * 2015-04-08 2016-10-13 Merial, Inc. Extended release injectable formulations comprising an isoxazoline active agent, methods and uses thereof
KR20190093571A (ko) 2016-12-09 2019-08-09 바이엘 애니멀 헬스 게엠베하 제약 제제 및 그의 제조 방법
PL3609470T3 (pl) * 2017-04-13 2024-04-15 Ceva Santé Animale Implant do leczenia infekcji pasożytniczej
KR102101969B1 (ko) * 2017-09-06 2020-04-22 (주)인벤티지랩 목시덱틴을 포함하는 마이크로 입자 및 이의 제조 방법
JP7274479B2 (ja) * 2017-11-23 2023-05-16 セバ・サンテ・アニマル 寄生虫の寄生を治療するためのモキシデクチンを含有する組成物
AU2021335500A1 (en) 2020-09-04 2023-05-04 Elanco Us Inc. Palatable formulations
CN119677500A (zh) 2022-06-30 2025-03-21 维克公司 德舍瑞林在与pk/pd相互作用相关的非人类哺乳动物化学去势中的用途

Family Cites Families (93)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6426333B1 (en) 1996-09-19 2002-07-30 Merial Spot-on formulations for combating parasites
FR2753377B1 (fr) 1996-09-19 1999-09-24 Rhone Merieux Nouvelle association parasiticide a base de 1-n-phenylpyra- zoles et de lactones macrocycliques endectocides
NL160809C (nl) 1970-05-15 1979-12-17 Duphar Int Res Werkwijze ter bereiding van benzoylureumverbindingen, alsmede werkwijze ter bereiding van insekticide prepara- ten op basis van benzoylureumverbindingen.
US3818047A (en) 1972-08-07 1974-06-18 C Henrick Substituted pyrones
SE434277B (sv) 1976-04-19 1984-07-16 Merck & Co Inc Sett att framstella nya antihelmintiskt verkande foreningar genom odling av streptomyces avermitilis
US4166452A (en) 1976-05-03 1979-09-04 Generales Constantine D J Jr Apparatus for testing human responses to stimuli
CH604517A5 (es) 1976-08-19 1978-09-15 Ciba Geigy Ag
US5089490A (en) 1977-04-02 1992-02-18 Hoechst Aktiengesellschaft Cephem derivatives
US4256108A (en) 1977-04-07 1981-03-17 Alza Corporation Microporous-semipermeable laminated osmotic system
US4134973A (en) 1977-04-11 1979-01-16 Merck & Co., Inc. Carbohydrate derivatives of milbemycin and processes therefor
US4199569A (en) 1977-10-03 1980-04-22 Merck & Co., Inc. Selective hydrogenation products of C-076 compounds and derivatives thereof
US4144352A (en) 1977-12-19 1979-03-13 Merck & Co., Inc. Milbemycin compounds as anthelmintic agents
US4265874A (en) 1980-04-25 1981-05-05 Alza Corporation Method of delivering drug with aid of effervescent activity generated in environment of use
US4457920A (en) 1981-09-03 1984-07-03 Merck & Co., Inc. 4a-Substituted avermectin compounds
US4423209A (en) 1982-02-26 1983-12-27 Merck & Co., Inc. Processes for the interconversion of avermectin compounds
US4427663A (en) 1982-03-16 1984-01-24 Merck & Co., Inc. 4"-Keto-and 4"-amino-4"-deoxy avermectin compounds and substituted amino derivatives thereof
DE3235931A1 (de) 1982-09-29 1984-03-29 Bayer Ag, 5090 Leverkusen Koeder zur bekaempfung von ungeziefer
JPS59199673A (ja) 1983-04-25 1984-11-12 Sumitomo Chem Co Ltd 含窒素複素環化合物、その製造法およびそれを有効成分とする有害生物防除剤
US5106994A (en) 1984-06-05 1992-04-21 American Cyanamid Company Agents and method of production thereof
EP0165900A3 (de) 1984-06-08 1986-05-28 Ciba-Geigy Ag Neue Lactone, Verfahren zu ihrer Herstellung und ihre Verwendung in der Schädlingsbekämpfung
IL76708A (en) 1984-10-18 1990-01-18 Ciba Geigy Ag Substituted n-benzoyl-n'-(2,5-dichloro-4(1,1,2,3,3,3-hexafluoropropyloxy)-phenyl)ureas,their preparation and pesticidal compositions containing them
ATE67493T1 (de) 1985-02-04 1991-10-15 Bayer Agrochem Kk Heterocyclische verbindungen.
ES8800986A1 (es) 1985-07-27 1987-12-01 Pfizer Un procedimiento para la produccion de un nuevo derivado de avermectina
EP0237482A1 (de) 1986-03-06 1987-09-16 Ciba-Geigy Ag C(29)-Carbonyloxi-milbemycin-Derivate zur Bekämpfung von tier- und pflanzenparasitären Schädlingen
EP0246739B1 (en) 1986-03-25 1991-01-23 Sankyo Company Limited Macrolide compounds, their preparation and their use
CA1296329C (en) * 1986-06-06 1992-02-25 Derek R. Sutherland Macrolide compounds
EP0252879B1 (de) 1986-07-02 1992-05-06 Ciba-Geigy Ag Pestizide
US4758435A (en) * 1986-08-11 1988-07-19 American Cyanamid Company Estradiol implant composition and method for preparation
US4916154A (en) 1986-09-12 1990-04-10 American Cyanamid Company 23-Imino derivatives of LL-F28249 compounds
US4831016A (en) 1986-10-31 1989-05-16 Merck & Co., Inc. Reduced avermectin derivatives
US4855317A (en) 1987-03-06 1989-08-08 Ciba-Geigy Corporation Insecticides and parasiticides
US4806527A (en) 1987-03-16 1989-02-21 Merck & Co., Inc. Avermectin derivatives
US4871719A (en) 1987-03-24 1989-10-03 Ciba-Geigy Corporation Composition for controlling parasites in productive livestock
US4874749A (en) 1987-07-31 1989-10-17 Merck & Co., Inc. 4"-Deoxy-4-N-methylamino avermectin Bla/Blb
DE3888936T2 (de) 1987-11-03 1994-07-21 Beecham Group Plc Zwischenprodukte für die Herstellung makrolider Antibiotika mit anthelmintischer Wirkung.
US4895837A (en) 1988-01-29 1990-01-23 Merck & Co., Inc. Avermectin derivatives
US4873224A (en) 1988-05-23 1989-10-10 Merck & Co., Inc. Avermectin derivatives
US4906619A (en) 1988-07-22 1990-03-06 Merck & Co., Inc. Alkyl avermectin derivatives
US5015630A (en) 1989-01-19 1991-05-14 Merck & Co., Inc. 5-oxime avermectin derivatives
NZ232422A (en) 1989-02-16 1992-11-25 Merck & Co Inc 13-ketal milbemycin derivatives and parasiticides
US5030622A (en) 1989-06-02 1991-07-09 Merck & Co., Inc. Avermectin derivatives
US5057499A (en) 1989-06-02 1991-10-15 Merck & Co. Inc. Avermectin derivatives
US5023241A (en) 1989-07-31 1991-06-11 Merck & Co., Inc. Avermectin derivatives
US4988824A (en) 1989-09-11 1991-01-29 Maulding Donald R Process for the preparation of 23-(C1-C6 alkyloxime)-LL-F28249 compounds
US5055454A (en) 1989-10-30 1991-10-08 Merck & Co., Inc. 13-epi-avermectin derivatives useful as antiparasitic agents
US5830875A (en) 1989-10-30 1998-11-03 Merck & Co., Inc. 24-and 25-substituted avermectin and milbemycin derivatives
IE904606A1 (en) 1989-12-21 1991-07-03 Beecham Group Plc Novel products
US5169839A (en) 1990-05-11 1992-12-08 Merck & Co., Inc. Derivatives of 3'- and 3"-o-desmethyl avermectin compounds, compositions and methods of treating melmintic and parasitic infections
US5733566A (en) 1990-05-15 1998-03-31 Alkermes Controlled Therapeutics Inc. Ii Controlled release of antiparasitic agents in animals
NZ239370A (en) 1990-08-22 1994-04-27 Merck & Co Inc Bioerodible implantable controlled release dosage form comprising a poly(ortho ester) or a polyacetal with an active agent incorporated into the chain backbone
US5208222A (en) 1991-03-28 1993-05-04 Merck & Co., Inc. 4"-and 4'-alkylthio avermectin derivatives
WO1992022555A1 (en) 1991-06-17 1992-12-23 Beecham Group Plc Paraherquamide derivatives, precursor thereof, processes for their preparation, microorganism used and their use as antiparasitic agents
US5262400A (en) 1991-06-20 1993-11-16 Merck & Co., Inc. 4α-substituted avermectin derivatives
US5162363A (en) 1992-03-18 1992-11-10 Merck & Co., Inc. 23-nor-23-thia avermectin analogs are active anthelmintic agents
US5244879A (en) 1992-03-18 1993-09-14 Merck & Co., Inc. 23-nor-23-oxa avermectin analogs are active anthelmintic agents
GB9300883D0 (en) 1993-01-18 1993-03-10 Pfizer Ltd Antiparasitic agents
US5399582A (en) 1993-11-01 1995-03-21 Merck & Co., Inc. Antiparasitic agents
US6221894B1 (en) 1995-03-20 2001-04-24 Merck & Co., Inc. Nodulisporic acid derivatives
US5962499A (en) 1995-03-20 1999-10-05 Merck & Co., Inc. Nodulisporic acid derivatives
TW334436B (en) 1995-07-21 1998-06-21 Upjohn Co Antiparasitic marcfortines and paraherquamides
US5885607A (en) 1996-03-29 1999-03-23 Rhone Merieux N-phenylpyrazole-based anti-flea and anti-tick external device for cats and dogs
US6010710A (en) 1996-03-29 2000-01-04 Merial Direct pour-on skin solution for antiparasitic use in cattle and sheep
IE80657B1 (en) 1996-03-29 1998-11-04 Merial Sas Insecticidal combination to control mammal fleas in particular fleas on cats and dogs
FR2752525B1 (fr) 1996-08-20 2000-05-05 Rhone Merieux Procede de lutte contre les myiases des cheptels bovins et ovins et compositions pour la mise en oeuvre de ce procede
FR2750861B1 (fr) 1996-07-11 1998-12-24 Rhone Merieux Procedes d'elimination des parasites, et notamment des ectoparasites de vertebres, notamment de mammiferes et compositions pour la mise en oeuvre de ce procede
US6998131B2 (en) 1996-09-19 2006-02-14 Merial Limited Spot-on formulations for combating parasites
US6207647B1 (en) 1997-07-18 2001-03-27 Smithkline Beecham Corporation RatA
ES2359973T3 (es) 1998-03-19 2011-05-30 MERCK SHARP & DOHME CORP. Composiciones poliméricas líquidas para la liberación controlada de sustancias bioactivas.
US6174540B1 (en) 1998-09-14 2001-01-16 Merck & Co., Inc. Long acting injectable formulations containing hydrogenated caster oil
GB9825402D0 (en) 1998-11-19 1999-01-13 Pfizer Ltd Antiparasitic formulations
US6787342B2 (en) 2000-02-16 2004-09-07 Merial Limited Paste formulations
PE20011289A1 (es) 2000-04-07 2001-12-21 Upjohn Co Composiciones antihelminticas que comprenden lactonas macrociclicas y espirodioxepinoindoles
RU2226531C1 (ru) 2000-04-27 2004-04-10 Санкио Компани, Лимитед 13-замещенные производные милбемицина, их получение и их применение против насекомых и других вредителей
US6399786B1 (en) 2000-07-14 2002-06-04 Merck & Co., Inc. Nonacyclic nodulisporic acid derivatives
AU2001278694A1 (en) 2000-08-09 2002-02-18 The Kitasato Institute Avermectin derivatives
AUPR602501A0 (en) 2001-06-29 2001-07-26 Smart Drug Systems Inc Sustained release pharmaceutical composition
AUPR610501A0 (en) * 2001-07-04 2001-07-26 Smart Drug Systems Inc Treatment of parasitic disease
US7001889B2 (en) 2002-06-21 2006-02-21 Merial Limited Anthelmintic oral homogeneous veterinary pastes
AR042420A1 (es) 2002-09-11 2005-06-22 Novartis Ag Benzotriazolil- aminoacetonitril compuestos, proceso para su preparacion, metodo y uso de los mismos en el control de endo- y ecto-parasitos dentro y sobre ganado productor de sangre caliente y animales domesticos y plantas, y en la preparacion de una composicion farmaceutica
US7326428B2 (en) 2002-12-18 2008-02-05 Evergreen Innovation Partners I, Lp Multi-compartment container and lid assembly
US7348417B2 (en) 2003-08-07 2008-03-25 Wyeth Method of purifying moxidectin through crystallization
US8221778B2 (en) * 2005-01-12 2012-07-17 The Trustees Of The University Of Pennsylvania Drug-containing implants and methods of use thereof
CN101768129B (zh) 2004-03-05 2012-05-23 日产化学工业株式会社 异*唑啉取代苯甲酰胺化合物的制备中间体
US8362086B2 (en) 2005-08-19 2013-01-29 Merial Limited Long acting injectable formulations
US20090143410A1 (en) 2005-12-14 2009-06-04 Kanu Maganbhai Patel Isoxazolines for Controlling Invertebrate Pests
TW200803740A (en) 2005-12-16 2008-01-16 Du Pont 5-aryl isoxazolines for controlling invertebrate pests
TWI412322B (zh) 2005-12-30 2013-10-21 Du Pont 控制無脊椎害蟲之異唑啉
EP2181100A2 (en) 2007-04-10 2010-05-05 Bayer CropScience AG Insecticidal aryl isoxazoline derivatives
US8088801B2 (en) 2007-05-15 2012-01-03 Merial Limited Aryloazol-2-yl cyanoethylamino compounds, method of making and method of using thereof
TWI430995B (zh) 2007-06-26 2014-03-21 Du Pont 萘異唑啉無脊椎有害動物控制劑
NO2957284T3 (es) 2007-06-27 2018-06-16
US8440633B2 (en) 2007-06-29 2013-05-14 Ah Usa 42 Llc Anthelmintic combination
TWI556741B (zh) 2007-08-17 2016-11-11 英特威特國際股份有限公司 異唑啉組成物及其作為抗寄生蟲藥上的應用

Also Published As

Publication number Publication date
US9044453B2 (en) 2015-06-02
AU2017268548B2 (en) 2019-09-19
AU2019229407A1 (en) 2019-10-03
BR112014013371A2 (pt) 2017-06-13
PL3351546T3 (pl) 2024-09-09
DK3351546T3 (da) 2024-04-29
MX358476B (es) 2018-08-22
CN105232529B (zh) 2018-11-23
AU2012345813A1 (en) 2014-07-03
US20130143956A1 (en) 2013-06-06
AU2012345813B2 (en) 2017-02-02
EP3351546B1 (en) 2024-02-14
AU2017200177B2 (en) 2017-11-23
HUE036441T2 (hu) 2018-07-30
ES2659159T3 (es) 2018-03-14
HK1201264A1 (en) 2015-08-28
ES2978407T3 (es) 2024-09-12
WO2013082373A1 (en) 2013-06-06
ZA201404122B (en) 2015-09-30
DK3351546T5 (da) 2024-08-12
PT2785719T (pt) 2018-02-08
PL2785719T3 (pl) 2018-03-30
PT3351546T (pt) 2024-03-07
HUE067125T2 (hu) 2024-10-28
BR112014013371B1 (pt) 2020-04-07
BR122020002199B1 (pt) 2021-01-19
NZ626149A (en) 2016-06-24
US20140323559A1 (en) 2014-10-30
EP2785719B1 (en) 2017-11-08
HK1256641A1 (en) 2019-09-27
CA3082432A1 (en) 2013-06-06
CN105232529A (zh) 2016-01-13
AU2017268548A1 (en) 2018-01-04
CA2857958A1 (en) 2013-06-06
MX2014006601A (es) 2015-03-05
US8715711B2 (en) 2014-05-06
CA2857958C (en) 2020-08-25
CN104053660B (zh) 2016-12-28
CN104053660A (zh) 2014-09-17
EP2785719A1 (en) 2014-10-08
DK2785719T3 (en) 2017-12-04
EP3351546A1 (en) 2018-07-25
AU2017200177A1 (en) 2017-02-02
EP3351546B9 (en) 2024-07-10
CA3082432C (en) 2023-01-03

Similar Documents

Publication Publication Date Title
MX379693B (es) Formulaciones de moxidectina inyectables de larga acción y formas de cristal de moxidectina novedosas.
NI201700011A (es) 2-(morfolin-4-il)-1,7-naftiridinas.
CO2018013978A2 (es) Derivados de ácido borónico y usos terapéuticos de los mismos.
CL2017003404A1 (es) Compuestos antibacterianos
UY36966A (es) Derivados de heterociclos bicíclicos fusionados como plaguicidas
CL2014002087A1 (es) Composición veterinaria masticable que comprende como agente activo un compuesto derivado de isoxazolina; y su uso para el tratamiento y/o prevención de una infestación y/o infección por parásitos en un animal.
CO2017002268A2 (es) Inhibidores espirocíclicos de catepsina c
UY35991A (es) Bencimidazol-2-aminas como inhibidores de midh1
CL2017002037A1 (es) 2-tioimidazolilcarboxamidas sustituidas como pesticidas.
DOP2016000226A (es) Compuestos de isoindolinona como moduladores de gpr119 para el tratamiento de diabetes, obesidad, dislipidemia y trastornos relacionados
CR20160433A (es) Nuevos compuestos
CO6771450A2 (es) Ureas asimétricas y usos médicos de las mismas
MX2019006893A (es) Inhibidores heterociclicos de mct4.
UY36000A (es) ?compuestos microbicidas, método para controlar o prevenir la infestación de microorganismos fitopa togenos, y composición de los mismos?.
CR20160235A (es) Tienopirimidinas como inhibidores mknk1 y mknk2
DOP2017000146A (es) Pirazolpiridinaminas como inhibidores de mknk1 y mknk2
ECSP22012650A (es) Composiciones que comprenden tigolaner para el control de parásitos
PE20150167A1 (es) (r)-nifuratel, su uso para el tratamiento de las infecciones y sintesis de (r) y (s)-nifuratel
ECSP13013075A (es) Método de tratamiento de la fiebre dengue
CR20160016A (es) Pirazolpiridinas sustituidas
DK3103453T3 (da) Medicinsk sammensætning omfattende heterocyklisk diamino-carboxamidforbindelse som aktiv bestanddel
CL2016002879A1 (es) Composiciones farmacéuticas para tratar enfermedades infecciosas
BR112014013613A2 (pt) composição antimicrobiana, método de desinfecção de uma superfície e uso de uma composição
DOP2017000018A (es) [1,2,4]triazolo[4,3-b]piridazinas para su uso en el tratamiento de enfermedades proliferativas
CL2014001862A1 (es) Compuestos derivados de morofolinilo sustituido, útiles como inhibidores de mogat-2; composicion farmaceutica que los comprende; uso en el tratamiento de hipertrigliceridemia.